< Previous Page
If Armstrong loses Tour titles, who gets them?
The cyclists Lance Armstrong beat to win his seven Tour de France victories may soon get a chance at his titles. But their ranks include men who have faced a tangle of doping bans and accusations, possibly presenting a headache for Tour leadership.
Here’s a look at who else was on the podium in the seven Tours that Armstrong won from 1999-2005:
No. 2 » Alex Zulle, Switzerland. His 1998 team, Festina, was ousted from the Tour that year in connection with the widespread use of the performance-enhancing drug EPO. Zulle later admitted to using the blood-booster over the four previous years. The Festina affair nearly derailed the 1998 Tour, and is widely seen as the first big doping scandal to jolt cycling.
No. 3 » Fernando Escartin, Spain.
No 2 » Jan Ullrich, Germany. The 1997 Tour winner, a five-time Tour runner-up and longtime Armstrong rival. He was the top-name cyclist among at least 50 implicated in the “Operation Puerto” police investigation in Spain in May 2006. Ullrich was stripped of his third-place finish from the 2005 Tour and retired from racing two years later. Earlier this year, he confirmed that he had had contact with Eufemiano Fuentes, a Spanish doctor at the center of that scandal, calling it a “big mistake” — but did not admit to doping.
No. 3 » Joseba Beloki, Spain. Implicated in Operation Puerto, he retired in 2007. He was reportedly was cleared by a Spanish court of any involvement in the case.
No 2 » Ullrich.
No. 3 » Beloki.
No. 2 » Beloki.
No. 3 » Raimondas Rumsas, Lithuania. On the last day of the 2002 Tour, police stopped his wife, Edita, at the Italian border and searched her car, turning up suspected doping products. A French court later handed them four-month prison sentences on doping-related charges. The cyclist denied taking banned substances at that event, and all his tests came back negative. He said the products in his wife’s car were for his mother-in-law. The next year, he was given a one-year ban after testing positive for EPO in the 2003 Giro d’Italia.
No. 2 » Ullrich.
No. 3 » Alexandre Vinokourov, Kazakhstan. He later served a two-year doping suspension after twice testing positive for banned blood transfusions during the 2007 race. He won the Olympic road race in London last month and has announced plans to retire.
No. 2 » Andreas Kloeden, Germany.
No. 3 » Ivan Basso, Italy. Excluded from the 2006 Tour because of his involvement in Operation Puerto. He claimed that he gave his blood to Fuentes — the Spanish doctor at the center of that scandal — but never used it. Later that year, Basso received a two-year doping ban; he later returned, and won his second Giro d’Italia in 2010.
No. 2 » Basso.
No. 3 » Ullrich.
USADA statement on Lance Armstrong
Statement issued by the U.S. Anti-Doping Agency on Friday:
USADA announced today that Lance Armstrong has chosen not to move forward with the independent arbitration process and as a result has received a lifetime period of ineligibility and disqualification of all competitive results from August 1, 1998 through the present, as the result of his anti-doping rule violations stemming from his involvement in the United States Postal Service (USPS) Cycling Team Doping Conspiracy (USPS Conspiracy).
Following the dismissal of Mr. Armstrong’s lawsuit on Monday, August 20, 2012, by the federal court in Austin, Texas, Mr. Armstrong had until midnight on Thursday, August 23, to contest the evidence against him in a full evidentiary hearing with neutral arbitrators as provided by U.S. law. However, when given the opportunity to challenge the evidence against him, and with full knowledge of the consequences, Mr. Armstrong chose not to contest the fact that he engaged in doping violations from at least August 1, 1998 and participated in a conspiracy to cover up his actions. As a result of Mr. Armstrong’s decision, USADA is required under the applicable rules, including the World Anti-Doping Code under which he is accountable, to disqualify his competitive results and suspend him from all future competition.
“Nobody wins when an athlete decides to cheat with dangerous performance enhancing drugs, but clean athletes at every level expect those of us here on their behalf, to pursue the truth to ensure the win-at-all-cost culture does not permanently overtake fair, honest competition” said USADA CEO, Travis T. Tygart. “Any time we have overwhelming proof of doping, our mandate is to initiate the case through the process and see it to conclusion as was done in this case.”
As is every athlete’s right, if Mr. Armstrong would have contested the USADA charges, all of the evidence would have been presented in an open legal proceeding for him to challenge. He chose not to do this knowing these sanctions would immediately be put into place.
The evidence against Lance Armstrong arose from disclosures made to USADA by more than a dozen witnesses who agreed to testify and provide evidence about their firsthand experience and/or knowledge of the doping activity of those involved in the USPS Conspiracy as well as analytical data. As part of the investigation Mr. Armstrong was invited to meet with USADA and be truthful about his time on the USPS team but he refused.
On June 12, 2012, USADA issued a notice letter informing Mr. Armstrong and five other individuals, including the USPS team director, team trainer and three team doctors, of USADA’s intent to open proceedings against them. On June 28, 2012, following a review process set forth in the applicable rules, USADA notified Mr. Armstrong and the other five individuals that the independent review panel’s finding confirmed sufficient and in fact overwhelming evidence, and that USADA was charging them with rule violations.
Numerous witnesses provided evidence to USADA based on personal knowledge acquired, either through direct observation of doping activity by Armstrong or through Armstrong’s admissions of doping to them that Armstrong used EPO, blood transfusions, testosterone and cortisone during the period from before 1998 through 2005, and that he had previously used EPO, testosterone and hGH through 1996. Witnesses also provided evidence that Lance Armstrong gave to them, encouraged them to use and administered doping products or methods, including EPO, blood transfusions, testosterone and cortisone during the period from 1999 through 2005. Additionally, scientific data showed Mr. Armstrong’s use of blood manipulation including EPO or blood transfusions during Mr. Armstrong’s comeback to cycling in the 2009 Tour de France.
The anti-doping rule violations for which Mr. Armstrong is being sanctioned are:
(1)Use and/or attempted use of prohibited substances and/or methods including EPO, blood transfusions, testosterone, corticosteroids and masking agents.
(2)Possession of prohibited substances and/or methods including EPO, blood transfusions and related equipment (such as needles, blood bags, storage containers and other transfusion equipment and blood parameters measuring devices), testosterone, corticosteroids and masking agents.
(3)Trafficking of EPO, testosterone, and corticosteroids.
(4)Administration and/or attempted administration to others of EPO, testosterone, and cortisone.
(5)Assisting, encouraging, aiding, abetting, covering up and other complicity involving one or more anti-doping rule violations and/or attempted anti-doping rule violations.
These activities are defined as anti-doping rule violations under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, USA Cycling rules and the International Cycling Union (UCI) Anti-Doping Rules (UCI ADR), all of which have adopted the World Anti-Doping Code (Code) and the World Anti-Doping Agency (WADA) Prohibited List.
In accordance with the Code, aggravating circumstances including involvement in multiple anti-doping rule violations and participation in a sophisticated doping scheme and conspiracy as well as trafficking, administration and/or attempted administration of a prohibited substance or method, justify a period of ineligibility greater than the standard sanction. Accordingly, Mr. Armstrong has received a lifetime period of ineligibility for his numerous anti-doping rule violations, including his involvement in trafficking and administering doping products to others. A lifetime period of ineligibility as described in the Code prevents Mr. Armstrong from participating in any activity or competition organized by any signatory to the Code or any member of any signatory.
In addition to the lifetime ban, Mr. Armstrong will be disqualified from any and all competitive results obtained on and subsequent to August 1, 1998, including forfeiture of any medals, titles, winnings, finishes, points and prizes.
As noted above, Mr. Armstrong challenged the arbitration process in federal court. In response, the court found that “the USADA arbitration rules, which largely follow those of the American Arbitration Association (AAA) are sufficiently robust to satisfy the requirements of due process.” USADA’s rules provide that where an athlete or other person is sanctioned because they fail to contest USADA’s charges in arbitration, the sanction shall not be reopened or subject to appeal unless the athlete or other person can demonstrate that he did not receive actual or constructive notice of the opportunity to contest the sanction. Because Mr. Armstrong could have had a hearing before neutral arbitrators to contest USADA’s evidence and sanction and he voluntarily chose not to do so, USADA’s sanction is final.
In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.
UCI statement on Lance Armstrong
Statement issued Friday by the International Cycling Union in regard to Lance Armstrong:
“The UCI notes Lance Armstrong’s decision not to proceed to arbitration in the case that USADA has brought against him.
The UCI recognizes that USADA is reported as saying that it will strip Mr. Armstrong of all results from 1998 onwards in addition to imposing a lifetime ban from participating in any sport which recognizes the World Anti-Doping Code.
Article 8.3 of the WADC states that where no hearing occurs the Anti-Doping Organization with results management responsibility shall submit to the parties concerned (Mr. Armstrong, WADA and UCI) a reasoned decision explaining the action taken.
As USADA has claimed jurisdiction in the case the UCI expects that it will issue a reasoned decision in accordance with Article 8.3 of the Code.
Until such time as USADA delivers this decision the UCI has no further comment to make.”
Copyright 2013 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.